Japan’s Prime Minister Ishiba denies reports suggesting he could resign in August: Reuters

Japan’s Prime Minister Ishiba denies reports suggesting he could resign in August: Reuters


Japan’s Prime Minister Shigeru Ishiba addresses the media at the vote counting center in the Liberal Democratic Party headquarters in Tokyo on July 20, 2025.

Franck Robichon | Afp | Getty Images

Japan’s embattled Prime Minister Shigeru Ishiba has denied media reports that he was considering resigning, according to Reuters.

Local media outlets earlier in the day said that Ishiba was unsure of his future and would take a call on whether to continue as prime minister in August.

On Wednesday, U.S. President Donald Trump announced that he had reached a “massive Deal” with Japan, potentially strengthening Ishiba’s leadership, just days after Japan’s governing coalition lost its majority in the country’s upper house elections.

Japan’s Mainichi newspaper reported Wednesday that the prime minister intended to announce his resignation by August, according to a Google translation of the report in Japanese.

Japanese media outlet Yomiuri had reported earlier in the day that Ishiba would decide whether to stay on as prime minister after assessing the progress of tariff negotiations.

Japan’s Jiji Press reported that “he would soon decide whether to step down or not,” adding that a senior member of Ishiba’s Liberal Democratic Party predicted that Ishiba would step down in August.

The Sankei newspaper, likewise, said that he would make the final decision on his future in August, and added that if he decides to step down, Ishiba would be expected to select a new party leader in September and hold an election for the nominee in October.

Some reports, such as the Nikkei newspaper’s, revealed that Ishiba will on Wednesday be in an “unusual” meeting with LDP Chief Advisor Taro Aso, Vice President Yoshihide Suga, and former Prime Minister Fumio Kishida.

Nikkei also said that Ishiba “will discuss his future with the former prime minister.” Ishiba said that he did not discuss his resignation, and “shared [a] strong sense of crisis with the former prime minister,” Reuters reported.

With the upper house loss, this is the first time that the LDP is a minority in both houses. The party lost its majority in the lower house last October.

Ishiba himself has not made any public remarks on his future, only saying after the election that he would stay on as prime minister.



Source

Sam Altman touts ChatGPT’s reaccelerating growth to employees as OpenAI closes in on 0 billion funding
World

Sam Altman touts ChatGPT’s reaccelerating growth to employees as OpenAI closes in on $100 billion funding

As OpenAI faces intensifying pressure from rival Anthropic’s improved coding tools, CEO Sam Altman is telling employees and investors that his company is seeing its share of momentum. Altman told OpenAI employees on Friday that ChatGPT, the company’s popular artificial intelligence chatbot, is “back to exceeding 10% monthly growth,” according to an internal Slack message […]

Read More
Databricks completes  billion funding round at 4 billion valuation
World

Databricks completes $5 billion funding round at $134 billion valuation

Ali Ghodsi, co-founder and CEO of Databricks. Databricks Databricks said Monday it has raised $5 billion in funding and $2 billion in new debt capacity at a $134 billion valuation. The privately held data analytics software company also said that its annualized revenue exceeded $5.4 billion for the January quarter, up 65% year over year, […]

Read More
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
World

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. Tom Little | Reuters Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in […]

Read More